Skip to main content

Table 3 Adverse events and laboratory abnormality during the treatment period

From: Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study

Adverse events

Clinical events (n = 10)

[n (%)]

 

Any grade

≥Grade 3

Diarrhea

4 (13.3)

0

Headache

2 (6.7)

0

Bloating

2 (6.7)

0

Fatigue

1 (3.3)

0

ALT increased

1 (3.3)

0

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us